Drug Type Small molecule drug |
Synonyms BrdU, BrdUrd, Bromodeoxyuridine + [6] |
Target |
Action modulators |
Mechanism DNA modulators(DNA modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedNDA/BLA |
First Approval Date- |
RegulationOrphan Drug (United States) |
Molecular FormulaC9H11BrN2O5 |
InChIKeyWOVKYSAHUYNSMH-RRKCRQDMSA-N |
CAS Registry59-14-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01763 | Broxuridine | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Brain Cancer | NDA/BLA | United States | - | - |
Brain Cancer | NDA/BLA | - | - | |
Brain Cancer | NDA/BLA | - | - | |
Breast Cancer | NDA/BLA | United States | - | - |
Breast Cancer | NDA/BLA | - | - | |
Breast Cancer | NDA/BLA | - | - | |
Adenocarcinoma of prostate | Phase 2 | United States | 01 Jul 1999 | |
Acute Myeloid Leukemia | Phase 2 | United States | 01 Apr 1998 |